Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2021-05-18 Director's Dealing
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2021-05-18 English
FORM 4
Director's Dealing
2021-05-18 English
FORM 4
Director's Dealing
2021-05-18 English
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 12, 2021, reporting on the results of the company's Annual Meeting of shareholders. It includes detailed voting results on director elections, advisory votes on executive compensation, ratification of the independent auditor, and approval of an amendment to the incentive plan. The content focuses on shareholder voting outcomes and changes related to directors and executive compensation plans. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes at any general meeting. The document is not a full annual report, proxy statement, or management discussion, but specifically the voting results announcement. The document length (6110 characters) and detailed vote counts support this classification with high confidence.
2021-05-18 English
FORM 4
Director's Dealing
2021-05-14 English
FORM 4
Director's Dealing
2021-05-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.